CME
This activity is provided by Partners for Advancing Clinical Education (PACE), DKBmed and the Institute for Johns Hopkins Nursing (IJHN). This activity is supported by in-kind support from DKBmed.
Enduring internet activity
Estimated time to complete this activity: 30 minutes
There is no fee for this educational activity.
Program release: August 17, 2022
Program expires: August 16, 2023
For CME questions, please visit https://partnersed.com/. For CNE NCPD questions, please contact the IJHN office at [email protected]
Target Audience
This initiative is designed to reach clinicians currently identifying and managing patients with monkeypox, including but not limited to providers working in primary care, emergency departments, urgent care, and other settings.
Learner Outcomes
After completing this activity, the participant should be better able to:
- Describe the clinical presentation and disease course of monkeypox (MPX)
- Assess the safety and efficacy of vaccinations and treatments for MPX
- Discuss strategies to improve quality of testing for Monkeypox virus
Faculty
Paul Auwaerter, MD, MBA, FIDSA
Clinical Director, Division of Infectious Diseases
Sherrilyn and Ken Fisher Professor of Medicine
Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE), and DKBmed, and the Institute for Johns Hopkins Nursing. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
PACE designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The maximum number of hours awarded for this nursing continuing professional development activity is 0.5 contact hours. This 0.5 contact hour NCPD activity is provided by the Institute for Johns Hopkins Nursing. Statements will be awarded for this educational activity until August 16, 2023.
Accreditation Statement
The Institute for Johns Hopkins Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Policy on Privacy and Confidentiality
Please see final activity for the policy on privacy and confidentiality that relates to this internet activity.
Disclosure of Conflicts of Interest
IHJN and PACE require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE and IJHN policy. IHJN and PACE are committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty / Presenter Reported Financial Relationship
Paul G. Auwaerter, MD, MBA, FIDSA
JNJ: Ownership equity
Scientific Consulting: Verily, EMD Serono, Shionogi
DMSB: Humanigen
Planners and Managers
The PACE planners and managers have nothing to disclose. The DKBmed planners and managers have nothing to disclose. The IJHN Nurse Planner has nothing to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Non-Endorsement of Products
The Institute for Johns Hopkins Nursing and the American Nurses Credentialing Center do not endorse the use of any commercial products discussed or displayed in conjunction with this educational activity.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of the IJHN name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.
Request for Credit/Fees
There are no fees for participating and receiving CME/CE NCPD contact hours credit for this activity. During the period of August 17, 2022 through August 16 2023, participants must read the learning objectives and faculty disclosures and study the educational activity. In order to receive NCPD contact hours, participants must also complete and submit an evaluation. If you wish to receive acknowledgment for completing this activity, please complete the evaluation.
Hardware/Software Requirements
Include minimum hardware, software, internet connectivity and connection speed requirements for accessing the internet-based activity.